DNA polymeraseη protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy

BACKGROUND: DNA polymerase η (pol η) is capable of bypassing DNA adducts produced by cisplatin or oxaliplatin and is associated with cellular tolerance to platinum. Previous studies showed that defective pol η resulted in enhanced cisplatin or oxaliplatin sensitivity in some cell lines. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Kai-yuan, Qiu, Miao-zhen, Li, Zhuang-hua, Luo, Hui-yan, Zeng, Zhao-lei, Luo, Rong-zhen, Zhang, Hui-zhong, Wang, Zhi-qiang, Li, Yu-hong, Xu, Rui-hua
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003639/
https://www.ncbi.nlm.nih.gov/pubmed/21110884
http://dx.doi.org/10.1186/1479-5876-8-126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003639/
https://www.ncbi.nlm.nih.gov/pubmed/21110884
http://dx.doi.org/10.1186/1479-5876-8-126

Ejemplares similares